Korea Arlico Pharm Co Ltd

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

Div yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

28.61%

Revenues

Net income

CFO

No notes on this company yet

Write a private note on this company, for your eyes only

Jae Hui Choi

Chief Executive Officer, Director · since 2019

Sun Eon Hong

Vice President

Ha Yeon Cho

Assistant Managing Director

Ha Gyeong Jeon

Assistant Managing Director

Yun Taek Oh

Assistant Managing Director

Su Won Shin

Internal Auditor

Hang Gu Lee

Director · since 2022

Ju Yeon Jang

Non-Executive Independent Director

URL

IPO date

Feb 12, 2018

Employees

Domiciled in

Incorporated in

No data to show